These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8889695)

  • 21. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
    di Clemente N; Wilson C; Faure E; Boussin L; Carmillo P; Tizard R; Picard JY; Vigier B; Josso N; Cate R
    Mol Endocrinol; 1994 Aug; 8(8):1006-20. PubMed ID: 7997230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of estrogen receptor alpha (ER alpha) in the regulation of the human Müllerian inhibitory substance (MIS) promoter.
    Chen G; Shinka T; Kinoshita K; Yan HT; Iwamoto T; Nakahori Y
    J Med Invest; 2003 Aug; 50(3-4):192-8. PubMed ID: 13678390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
    Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
    Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
    Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
    Catlin EA; Tonnu VC; Ebb RG; Pacheco BA; Manganaro TF; Ezzell RM; Donahoe PK; Teixeira J
    Endocrinology; 1997 Feb; 138(2):790-6. PubMed ID: 9003016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic studies of the AMH/MIS signaling pathway for Müllerian duct regression.
    Jamin SP; Arango NA; Mishina Y; Hanks MC; Behringer RR
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):15-9. PubMed ID: 14656471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo.
    Stephen AE; Pearsall LA; Christian BP; Donahoe PK; Vacanti JP; MacLaughlin DT
    Clin Cancer Res; 2002 Aug; 8(8):2640-6. PubMed ID: 12171896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene.
    Hoshiya M; Christian BP; Cromie WJ; Kim H; Zhan Y; MacLaughlin DT; Donahoe PK
    Birth Defects Res A Clin Mol Teratol; 2003 Oct; 67(10):868-74. PubMed ID: 14745940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody to Mullerian inhibiting substance.
    Mudgett-Hunter M; Budzik GP; Sullivan M; Donahoe PK
    J Immunol; 1982 Mar; 128(3):1327-33. PubMed ID: 6895760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence, genomic organization, and chromosomal location of the mouse Müllerian-inhibiting substance type II receptor gene.
    Mishina Y; Tizard R; Deng JM; Pathak BG; Copeland NG; Jenkins NA; Cate RL; Behringer RR
    Biochem Biophys Res Commun; 1997 Aug; 237(3):741-6. PubMed ID: 9299437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport.
    Belville C; Maréchal JD; Pennetier S; Carmillo P; Masgrau L; Messika-Zeitoun L; Galey J; Machado G; Treton D; Gonzalès J; Picard JY; Josso N; Cate RL; di Clemente N
    Hum Mol Genet; 2009 Aug; 18(16):3002-13. PubMed ID: 19457927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMH and AMH receptor defects in persistent Müllerian duct syndrome.
    Josso N; Belville C; di Clemente N; Picard JY
    Hum Reprod Update; 2005; 11(4):351-6. PubMed ID: 15878900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different patterns of anti-Müllerian hormone expression, as related to DMRT1, SF-1, WT1, GATA-4, Wnt-4, and Lhx9 expression, in the chick differentiating gonads.
    Oréal E; Mazaud S; Picard JY; Magre S; Carré-Eusèbe D
    Dev Dyn; 2002 Nov; 225(3):221-32. PubMed ID: 12412004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended production of the müllerian duct regressor in the American alligator.
    Austin HB
    Gen Comp Endocrinol; 1994 Oct; 96(1):122-8. PubMed ID: 7843560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of the anti-Müllerian hormone, the anti-Müllerian hormone receptor, and galactose-1-phosphate uridyl transferase genes in patients with the Mayer-Rokitansky-Küster-Hauser syndrome.
    Zenteno JC; Carranza-Lira S; Kofman-Alfaro S
    Arch Gynecol Obstet; 2004 May; 269(4):270-3. PubMed ID: 15221321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadoblastoma: immunohistochemical localization of Müllerian-inhibiting substance, inhibin, WT-1, and p53.
    Hussong J; Crussi FG; Chou PM
    Mod Pathol; 1997 Nov; 10(11):1101-5. PubMed ID: 9388060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMH signaling: from receptor to target gene.
    Visser JA
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):65-73. PubMed ID: 14656478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Setbacks on the road to sexual fulfillment.
    Nordqvist K; Lovell-Badge R
    Nat Genet; 1994 May; 7(1):7-9. PubMed ID: 8075645
    [No Abstract]   [Full Text] [Related]  

  • 39. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
    Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
    Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
    Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
    Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.